Profile of Nagoya University Hospital 2012

• Idea/Basic Decision
• Declaration Regarding Patients' Rights and Responsibilities
• Message From the Director

• Idea, Basic Decision, History
• Organization Chart of University Hospital
• Organization Chart of Administration Office
• Chronological List of Directors of University Hospital
• Established Date of Clinical Departments
• Clinical Departments
• Legal Authorization of Medical Services
• University Hospital Staff, Number of Staffs
• Number of Beds
• Patient Services in the University Hospital in 2011
• Clinical Indicator
• Access

Neurology

Director SOBUE, Gen (Professor)   10W

A large number of specialists flexibly provide medical care in response to the aging society

We perform activities such as diagnosis and treatment of neurodegenerative disease and dementia, which are expected to increase in the aging society, and stroke, which is one of the three major causes of death.

Medical Care System

More than 35 neurology specialists in our department provide medical care in the general outpatient clinic and specialized outpatient clinic and inpatient medical care. We provide accurate diagnosis and better treatment by utilizing techniques, such as the most advanced imaging devices, and various biopsies and electrophysiological technologies in which we have made extensive achievements.

Target Disease

Alzheimer's disease, dementia, Parkinson's disease, amyotrophic lateral sclerosis, bulbospinal muscular atrophy, spinocerebellar degeneration, multiple sclerosis, Guillain-Barre syndrome, myasthenia gravis, polymyositis, facial spasm, epilepsy, headache, dizziness, and numbness.

Strong Fields

Diagnosis and treatment of neurodegenerative disease such as dementia and Parkinson's disease using three-Tesla MRI, PET, and SPECT. Diagnosis and treatment of diseases such as peripheral nerve disease, muscular disease, spinal cord disease, and amyotrophic lateral sclerosis using biopsy, electrophysiological tests, and genetic testing.

Clinical Results

The annual number of outpatients: About 22,000; the annual number of new patients (only those with neurological disease): 1,255; the annual number of inpatients: 348.

Specialized Outpatient Clinic

We provide medical care in specialized outpatient clinics for bulbospinal muscular atrophy, amyotrophic lateral sclerosis, Parkinson's disease, and dementia. In addition, we are actively involved in the second opinion outpatient clinic.

Advanced Medicine and Research

A clinical study of leuprorelin in patients with bulbospinal muscular atrophy, a nationwide multi-center prospective cohort study in patients with amyotrophic lateral sclerosis (JaCALS), high-dose gamma globulin therapy and plasma exchange therapy for various intractable immunologic diseases, etc.